TargetedDeepSeq_Sample_18
Homo sapiens
On-target C-to-T editing frequencies of different treatment distinguished by barcode: 1:fig2b-2-3g-edfig4b_293FT_Non-treated_VEGFA2C_1; 2: fig2e_293FT_tBE-VLP1-20μl_VEGFA2C_3; 5:edfig7a_Hela_tBE-VLP2-2.5μl_VEGFA2C_3; 6:edfig7a_Hela_tBE-VLP2-20μl_VEGFA2C_3; 7:edfig7a_Hela_tBE-VLP2-5μl_VEGFA2C_3; 8:edfig7a_Hela_tBE-VLP2-10μl_VEGFA2C_3; 11:edfig7b_U2OS_tBE-VLP2-2.5μl_VEGFA2C_3; 12:edfig7b_U2OS_tBE-VLP2-5μl_VEGFA2C_1
isolate
DNA
age
NA
biomaterial_provider
Li Yang
collection_date
not collected
geo_loc_name
not applicable
sex
not applicable
tissue
NA
cell_line
293FT cells, U2OS cells, Hela cells
treatment
1:fig2b-2-3g-edfig4b_293FT_Non-treated_VEGFA2C_1; 2: fig2e_293FT_tBE-VLP1-20μl_VEGFA2C_3; 5:edfig7a_Hela_tBE-VLP2-2.5μl_VEGFA2C_3; 6:edfig7a_Hela_tBE-VLP2-20μl_VEGFA2C_3; 7:edfig7a_Hela_tBE-VLP2-5μl_VEGFA2C_3; 8:edfig7a_Hela_tBE-VLP2-10μl_VEGFA2C_3; 11:edfig7b_U2OS_tBE-VLP2-2.5μl_VEGFA2C_3; 12:edfig7b_U2OS_tBE-VLP2-5μl_VEGFA2C_1
BioSampleModel
Human